Product Overview

Captanexel 500 contains Capecitabine 500 mg, an oral anticancer medication used in the treatment of various malignancies, including colorectal cancer, breast cancer, and gastric cancer. It is a prodrug that is converted into 5-fluorouracil (5-FU) within the body, helping inhibit the growth and multiplication of cancer cells. The formulation is designed to provide effective cancer management through a convenient oral dosage form, making it an important component of modern oncology treatment protocols.

How It Works

Capecitabine is metabolized within the body to form 5-fluorouracil (5-FU), an active anticancer agent that interferes with DNA synthesis in rapidly dividing cancer cells. This mechanism helps slow down or stop the growth and spread of malignant cells while supporting established chemotherapy treatment strategies.

Therapeutic Applications

Captanexel 500 may be prescribed as part of treatment regimens for:

• Colorectal Cancer
• Metastatic Colorectal Cancer
• Breast Cancer
• Advanced Gastric Cancer
• Other oncology indications as determined by the treating oncologist

Key Benefits

• Convenient oral chemotherapy formulation.
• Widely used in established oncology treatment protocols.
• Supports the management of multiple cancer types.
• May be used as monotherapy or in combination with other anticancer agents.
• Helps reduce dependence on continuous intravenous chemotherapy administration.
• Manufactured under stringent pharmaceutical quality standards.

Quality Commitment

At Vinix Biopharma, Captanexel 500 is manufactured following strict quality control procedures to ensure safety, consistency, and reliability. Every stage of production is carefully monitored to meet pharmaceutical quality standards and support effective patient care.

Storage Information

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Disclaimer

Captanexel 500 should be used strictly under the supervision of a qualified oncologist or registered medical practitioner. Dosage and treatment duration should be determined by healthcare professionals based on individual patient requirements.